{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:47:33Z","timestamp":1788299253811,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s43032-019-00084-7","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T14:03:47Z","timestamp":1581689027000},"page":"823-832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Introduction of Somatic Mutation in MED12 Induces Wnt4\/\u03b2-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell"],"prefix":"10.1007","volume":"27","author":[{"given":"Abdeljabar","family":"El Andaloussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"issue":"5728","key":"84_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1126\/science.1112063","volume":"308","author":"CL Walker","year":"2005","unstructured":"Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589\u201392.","journal-title":"Science."},{"issue":"1","key":"84_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ogc.2005.12.001","volume":"33","author":"EE Marsh","year":"2006","unstructured":"Marsh EE, Bulun SE. Steroid hormones and leiomyomas. Obstet Gynecol Clin N Am. 2006;33(1):59\u201367.","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"1","key":"84_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ogc.2005.12.004","volume":"33","author":"M Payson","year":"2006","unstructured":"Payson M, Leppert P, Segars J. Epidemiology of myomas. Obstet Gynecol Clin N Am. 2006;33(1):1\u201311.","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"4","key":"84_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","volume":"22","author":"S Gupta","year":"2008","unstructured":"Gupta S, Jose J, Manyonda I. Clinical presentation of fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):615\u201326.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6053","key":"84_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N Makinen","year":"2011","unstructured":"Makinen N, Mehine M, Tolvanen J, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334(6053):252\u20135.","journal-title":"Science."},{"issue":"12","key":"84_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.18632\/oncotarget.370","volume":"2","author":"N Makinen","year":"2011","unstructured":"Makinen N, Heinonen HR, Moore S, Tomlinson IP, van der Spuy ZM, Aaltonen LA. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget. 2011;2(12):966\u20139.","journal-title":"Oncotarget."},{"issue":"7","key":"84_CR7","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","volume":"131","author":"DN Markowski","year":"2012","unstructured":"Markowski DN, Bartnitzke S, Loning T, Drieschner N, Helmke BM, Bullerdiek J. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups. Int J Cancer. 2012;131(7):1528\u201336.","journal-title":"Int J Cancer"},{"issue":"3","key":"84_CR8","doi-asserted-by":"publisher","first-page":"e33251","DOI":"10.1371\/journal.pone.0033251","volume":"7","author":"MM McGuire","year":"2012","unstructured":"McGuire MM, Yatsenko A, Hoffner L, Jones M, Surti U, Rajkovic A. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS One. 2012;7(3):e33251.","journal-title":"PLoS One"},{"issue":"2","key":"84_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00438-014-0938-x","volume":"290","author":"SK Halder","year":"2015","unstructured":"Halder SK, Laknaur A, Miller J, Layman LC, Diamond M, Al-Hendy A. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids. Gen Genomics. 2015;290(2):505\u201311.","journal-title":"Gen Genomics"},{"issue":"9","key":"84_CR10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/humu.22612","volume":"35","author":"K Kampjarvi","year":"2014","unstructured":"Kampjarvi K, Park MJ, Mehine M, et al. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Hum Mutat. 2014;35(9):1136\u201341.","journal-title":"Hum Mutat"},{"issue":"8","key":"84_CR11","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI81534","volume":"125","author":"P Mittal","year":"2015","unstructured":"Mittal P, Shin YH, Yatsenko SA, Castro CA, Surti U, Rajkovic A. Med12 gain-of-function mutation causes leiomyomas and genomic instability. J Clin Invest. 2015;125(8):3280\u20134.","journal-title":"J Clin Invest"},{"issue":"15","key":"84_CR12","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-08-4471","volume":"69","author":"JS Crabtree","year":"2009","unstructured":"Crabtree JS, Jelinsky SA, Harris HA, Choe SE, Cotreau MM, Kimberland ML, et al. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway. Cancer Res. 2009;69(15):6171\u20138.","journal-title":"Cancer Res"},{"issue":"5","key":"84_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.molcel.2004.05.011","volume":"14","author":"HM Bourbon","year":"2004","unstructured":"Bourbon HM, Aguilera A, Ansari AZ, Asturias FJ, Berk AJ, Bjorklund S, et al. A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II. Mol Cell. 2004;14(5):553\u20137.","journal-title":"Mol Cell"},{"issue":"5","key":"84_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrm1369","volume":"5","author":"DJ Taatjes","year":"2004","unstructured":"Taatjes DJ, Marr MT, Tjian R. Regulatory diversity among metazoan co-activator complexes. Nat Rev Mol Cell Biol. 2004;5(5):403\u201310.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"84_CR15","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1093\/nar\/gkn349","volume":"36","author":"HM Bourbon","year":"2008","unstructured":"Bourbon HM. Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex. Nucleic Acids Res. 2008;36(12):3993\u20134008.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"84_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1074\/jbc.M508253200","volume":"281","author":"Y Takagi","year":"2006","unstructured":"Takagi Y, Kornberg RD. Mediator as a general transcription factor. J Biol Chem. 2006;281(1):80\u20139.","journal-title":"J Biol Chem"},{"issue":"11","key":"84_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrg2901","volume":"11","author":"S Malik","year":"2010","unstructured":"Malik S, Roeder RG. The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet. 2010;11(11):761\u201372.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"84_CR18","first-page":"393","volume":"50","author":"AD Clark","year":"2015","unstructured":"Clark AD, Oldenbroek M, Boyer TG. Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol. 2015;50(5):393\u2013426.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"20","key":"84_CR19","doi-asserted-by":"publisher","first-page":"14066","DOI":"10.1074\/jbc.M602696200","volume":"281","author":"S Kim","year":"2006","unstructured":"Kim S, Xu X, Hecht A, Boyer TG. Mediator is a transducer of Wnt\/beta-catenin signaling. J Biol Chem. 2006;281(20):14066\u201375.","journal-title":"J Biol Chem"},{"issue":"13","key":"84_CR20","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1074\/jbc.RA118.001725","volume":"293","author":"MJ Park","year":"2018","unstructured":"Park MJ, Shen H, Spaeth JM, Tolvanen JH, Failor C, Knudtson JF, et al. Oncogenic exon 2 mutations in mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8\/19. J Biol Chem. 2018;293(13):4870\u201382.","journal-title":"J Biol Chem"},{"issue":"3","key":"84_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","volume":"7","author":"M Turunen","year":"2014","unstructured":"Turunen M, Spaeth JM, Keskitalo S, et al. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Rep. 2014;7(3):654\u201360.","journal-title":"Cell Rep"},{"issue":"10","key":"84_CR22","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/bjc.2012.428","volume":"107","author":"K Kampjarvi","year":"2012","unstructured":"Kampjarvi K, Makinen N, Kilpivaara O, et al. Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer. 2012;107(10):1761\u20135.","journal-title":"Br J Cancer"},{"issue":"1","key":"84_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/pros.23092","volume":"76","author":"K Kampjarvi","year":"2016","unstructured":"Kampjarvi K, Kim NH, Keskitalo S, et al. Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms. Prostate. 2016;76(1):22\u201331.","journal-title":"Prostate"},{"issue":"16","key":"84_CR24","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1242\/dev.053660","volume":"137","author":"PP Rocha","year":"2010","unstructured":"Rocha PP, Scholze M, Bleiss W, Schrewe H. Med12 is essential for early mouse development and for canonical Wnt and Wnt\/PCP signaling. Development. 2010;137(16):2723\u201331.","journal-title":"Development."},{"issue":"1","key":"84_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1756-8935-5-13","volume":"5","author":"T Prenzel","year":"2012","unstructured":"Prenzel T, Kramer F, Bedi U, Nagarajan S, Beissbarth T, Johnsen SA. Cohesin is required for expression of the estrogen receptor-alpha (ESR1) gene. Epigenetics Chromatin. 2012;5(1):13.","journal-title":"Epigenetics Chromatin"},{"issue":"4","key":"84_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1530\/ERC-14-0171","volume":"21","author":"Z Shaikhibrahim","year":"2014","unstructured":"Shaikhibrahim Z, Offermann A, Braun M, Menon R, Syring I, Nowak M, et al. MED12 overexpression is a frequent event in castration-resistant prostate cancer. Endocr Relat Cancer. 2014;21(4):663\u201375.","journal-title":"Endocr Relat Cancer"},{"key":"84_CR27","doi-asserted-by":"publisher","first-page":"17041","DOI":"10.1038\/cddiscovery.2017.41","volume":"3","author":"AE Andaloussi","year":"2017","unstructured":"Andaloussi AE, Habib S, Soylemes G, et al. Defective expression of ATG4D abrogates autophagy and promotes growth in human uterine fibroids. Cell Death Dis. 2017;3:17041.","journal-title":"Cell Death Dis"},{"issue":"6","key":"84_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","volume":"82","author":"SA Carney","year":"2002","unstructured":"Carney SA, Tahara H, Swartz CD, Risinger JI, He H, Moore AB, et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Investig. 2002;82(6):719\u201328.","journal-title":"Lab Investig"},{"issue":"1","key":"84_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.fertnstert.2010.07.1041","volume":"95","author":"C Sharan","year":"2011","unstructured":"Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril. 2011;95(1):247\u201353.","journal-title":"Fertil Steril"},{"issue":"6","key":"84_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1095\/biolreprod.113.107714","volume":"89","author":"SK Halder","year":"2013","unstructured":"Halder SK, Osteen KG, Al-Hendy A. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod. 2013;89(6):150.","journal-title":"Biol Reprod"},{"issue":"9","key":"84_CR31","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/humrep\/det265","volume":"28","author":"SK Halder","year":"2013","unstructured":"Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013;28(9):2407\u201316.","journal-title":"Hum Reprod"},{"issue":"4","key":"84_CR32","doi-asserted-by":"publisher","first-page":"E572","DOI":"10.1210\/jc.2014-4011","volume":"100","author":"A Al-Hendy","year":"2015","unstructured":"Al-Hendy A, Diamond MP, El-Sohemy A, Halder SK. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. J Clin Endocrinol Metab. 2015;100(4):E572\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"84_CR33","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1210\/jc.2010-2131","volume":"96","author":"SK Halder","year":"2011","unstructured":"Halder SK, Goodwin JS, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96(4):E754\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"84_CR34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrc1974","volume":"6","author":"DM Sabatini","year":"2006","unstructured":"Sabatini DM. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer. 2006;6(9):729\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"84_CR35","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.3892\/ol.2016.5289","volume":"12","author":"N Su","year":"2016","unstructured":"Su N, Wang P, Li Y. Role of Wnt\/beta-catenin pathway in inducing autophagy and apoptosis in multiple myeloma cells. Oncol Lett. 2016;12(6):4623\u20139.","journal-title":"Oncol Lett"},{"issue":"17","key":"84_CR36","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","volume":"372","author":"EA Stewart","year":"2015","unstructured":"Stewart EA. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372(17):1646\u201355.","journal-title":"N Engl J Med"},{"issue":"3","key":"84_CR37","doi-asserted-by":"publisher","first-page":"211 e1","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. American journal of obstetrics and gynecology. 2012;206(3):211 e1\u20139.","journal-title":"American journal of obstetrics and gynecology"},{"key":"84_CR38","doi-asserted-by":"crossref","unstructured":"Sohn GS, Cho S, Kim YM, Cho CH, Kim MR, Lee SR, Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstetrics & gynecology science 2018;61(2):192\u2013201.","DOI":"10.5468\/ogs.2018.61.2.192"},{"issue":"6","key":"84_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/PGP.0000000000000096","volume":"33","author":"DN Markowski","year":"2014","unstructured":"Markowski DN, Helmke BM, Bartnitzke S, Loning T, Bullerdiek J. Uterine fibroids: do we deal with more than one disease? Int J Gynecol Pathol. 2014;33(6):568\u201372.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"84_CR40","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.fertnstert.2014.06.040","volume":"102","author":"HR Heinonen","year":"2014","unstructured":"Heinonen HR, Sarvilinna NS, Sjoberg J, et al. MED12 mutation frequency in unselected sporadic uterine leiomyomas. Fertil Steril. 2014;102(4):1137\u201342.","journal-title":"Fertil Steril"},{"issue":"3","key":"84_CR41","first-page":"592","volume":"158","author":"A Al-Hendy","year":"2017","unstructured":"Al-Hendy A, Laknaur A, Diamond MP, Ismail N, Boyer TG, Halder SK. Silencing Med12 gene reduces proliferation of human leiomyoma cells mediated via Wnt\/beta-catenin signaling pathway. Endocrinology. 2017;158(3):592\u2013603.","journal-title":"Endocrinology."},{"issue":"6","key":"84_CR42","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985\u201399.","journal-title":"Cell."},{"issue":"9","key":"84_CR43","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc1692","volume":"5","author":"Y Kondo","year":"2005","unstructured":"Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5(9):726\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"84_CR44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489\u2013501.","journal-title":"Nat Rev Cancer"},{"issue":"6835","key":"84_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/35077225","volume":"411","author":"P Blume-Jensen","year":"2001","unstructured":"Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411(6835):355\u201365.","journal-title":"Nature."},{"key":"84_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2017.01.004","volume":"264","author":"ZZ Xie","year":"2017","unstructured":"Xie ZZ, Li MM, Deng PF, Wang S, Wang L, Lu XP, et al. Paris saponin-induced autophagy promotes breast cancer cell apoptosis via the Akt\/mTOR signaling pathway. Chem Biol Interact. 2017;264:1\u20139.","journal-title":"Chem Biol Interact"},{"issue":"20","key":"84_CR47","doi-asserted-by":"publisher","first-page":"10040","DOI":"10.1158\/0008-5472.CAN-06-0802","volume":"66","author":"C Cao","year":"2006","unstructured":"Cao C, Subhawong T, Albert JM, Kim KW, Geng L, Sekhar KR, et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res. 2006;66(20):10040\u20137.","journal-title":"Cancer Res"},{"issue":"13","key":"84_CR48","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/emboj.2013.123","volume":"32","author":"KJ Petherick","year":"2013","unstructured":"Petherick KJ, Williams AC, Lane JD, Ord\u00f3\u00f1ez-Mor\u00e1n P, Huelsken J, Collard TJ, et al. Autolysosomal beta-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J. 2013;32(13):1903\u201316.","journal-title":"EMBO J"},{"issue":"25","key":"84_CR49","doi-asserted-by":"publisher","first-page":"18573","DOI":"10.1074\/jbc.M701194200","volume":"282","author":"G Marino","year":"2007","unstructured":"Marino G, Salvador-Montoliu N, Fueyo A, Knecht E, Mizushima N, Lopez-Otin C. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C\/autophagin-3. J Biol Chem. 2007;282(25):18573\u201383.","journal-title":"J Biol Chem"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43032-019-00084-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T20:10:18Z","timestamp":1609791018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43032-019-00084-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s43032-019-00084-7","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}